Medical imaging markers

Brachytherapy markers with copper, brass, gold, or titanium inner rings and nickel or iron oxide coatings provide accurate positioning across CT and MRI, enhancing treatment precision and safety in brachytherapy procedures.

JP7581261B2Active Publication Date: 2024-11-12NUCLETRON OPERATIONS
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2021576894
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-06-27
Filing Date
2020-06-25
Publication Date
2024-11-12
Estimated Expiration
2040-06-25

AI Technical Summary

Technical Problem

Existing brachytherapy markers are not sufficiently accurate or reliable for determining the correct positioning of radiation sources across multiple imaging modalities, particularly in CT and MRI, leading to potential harm to healthy tissues and incomplete treatment of cancer cells.

Method used

Development of brachytherapy markers with specific materials and dimensions, such as copper, brass, gold, or titanium inner rings and nickel or iron oxide outer coatings, designed to create visible artifacts in both CT and MRI scans, allowing for precise positioning using electromagnetic sensors.

Benefits of technology

Enables accurate and real-time positioning of radiation sources, improving treatment precision and reducing the risk of damaging healthy tissues while ensuring targeted cancer treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581261000001
    Figure 0007581261000001
  • Figure 0007581261000002
    Figure 0007581261000002
  • Figure 0007581261000003
    Figure 0007581261000003
Patent Text Reader

Abstract

Embodiments of the present disclosure may be directed to brachytherapy markers. An exemplary marker may include an inner ring constructed from one or more of copper, brass, gold, silver, or titanium, an outer coating constructed from one or more of nickel or iron oxide that may be about 1 μm to about 30 μm thick, and a central opening that may be about 0.50 mm to about 3.00 mm in diameter.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] FIELD OF THE DISCLOSURE This disclosure relates generally to brachytherapy, and more particularly to brachytherapy markers designed for use across multiple imaging modalities. [Background technology]

[0002] During a high dose rate (HDR) brachytherapy procedure, a radiation source is introduced into or adjacent to a target volume of a patient, such as a tumor. The radiation source can be introduced manually or using an after-loader device. Typically, an after-loader device is used to deliver the radiation source to an area inside the patient for a period of time at a predetermined parking position. The radiation source can be introduced via a cable or catheter and can be positioned in a brachytherapy applicator that is pre-positioned inside the patient.

[0003] Accurate positioning of the radiation source in a target area of ​​the body is important to perform a prescribed brachytherapy treatment. For example, if the radiation source is not positioned accurately, the correct radiation dose may not be delivered to the intended target area. In addition, surrounding healthy structures may receive radiation instead of or in addition to the intended target area. Exposing the wrong area to radiation may ultimately harm or kill surrounding healthy cells, leaving cancer cells untreated or undertreated. Summary of the Invention [Problem to be solved by the invention]

[0004] To determine whether the radiation source and / or brachytherapy applicator is correctly positioned and therefore whether the radiation source is introduced to the correct target area, large markers that can be visualized using computed tomography (CT) images are often used, or electromagnetic coils for electromagnetic tracking may be used. However, such techniques may not be sufficiently accurate or reliable in determining the correct positioning of the radiation source. Furthermore, conventional markers may not be usable across multiple different imaging modalities. For example, a marker that is compatible with CT imaging may not be compatible for use with magnetic resonance imaging (MRI). Thus, it may be difficult or impossible to use conventional markers in both treatment planning and treatment administration. [Means for solving the problem]

[0005] Embodiments of the present disclosure may be directed to brachytherapy markers. An exemplary marker may include an inner ring constructed from one or more of copper, brass, gold, silver, or titanium, an outer coating constructed from one or more of nickel or iron oxide that may be about 1 μm to about 30 μm thick, and a central aperture that may be about 0.50 mm to about 3.00 mm in diameter.

[0006] Various embodiments of the present disclosure can include one or more of the following aspects: the inner ring can be copper or brass; the marker can be annular; the outer diameter of the marker can be about 1.00 mm to about 5.50 mm; the thickness of the outer coating can be about 4 μm to about 20 μm; or the diameter of the central opening can be about 0.75 mm to about 2.25 mm; the marker can be coupled to a distal region of a brachytherapy applicator, a brachytherapy needle, a brachytherapy catheter, or a brachytherapy transfer tube.

[0007] Embodiments of the present disclosure may also be directed to a method of positioning a brachytherapy device within a subject. The method includes inserting a brachytherapy device including a marker into the subject. The marker may include an inner ring comprised of one or more of copper, brass, gold, silver, or titanium, an outer coating comprised of one or more of nickel or iron oxide, the outer coating may be about 1 μm to about 30 μm thick, and a central opening may be about 0.50 mm to about 3.00 mm in diameter. The method also includes generating a magnetic resonance image of the brachytherapy device and the marker when inserted into the subject, the inner ring and the outer coating of the marker may be configured to produce an artifact in the image.

[0008] Various embodiments of the present disclosure may include one or more of the following aspects: adjusting the position of the brachytherapy device within the patient based on artifacts occurring in the image, generating a computed tomography image of the brachytherapy device, inserting an afterloader cable, which may include an electromagnetic sensor, into the brachytherapy device, detecting the markers using the electromagnetic sensor, inserting a source cable into the brachytherapy device and positioning the radiation source relative to the artifact. In other embodiments, the afterloader cable may be a dummy cable, the source cable may include a second electromagnetic sensor, or the electromagnetic sensor may be a coil.

[0009] Embodiments of the present disclosure may also be directed to a kit including a brachytherapy device and a marker, which may include an inner ring comprised of one or more of copper, brass, gold, silver, or titanium, an outer coating comprised of one or more of nickel or iron oxide, which may be about 1 μm to about 30 μm thick, and a central opening which may be about 0.50 mm to about 3.00 mm in diameter, and the marker may be annular.

[0010] Additional objects and advantages of embodiments of the present disclosure will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of embodiments of the present disclosure.

[0011] It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of embodiments of the present disclosure as claimed.

[0012] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various exemplary embodiments and, together with the description, serve to explain the principles of embodiments of the present disclosure.

[0013] For simplicity and clarity of illustration, the figures show the general structure and / or method of construction of the various embodiments described herein. For ease of illustration, the figures may show various components as uniform and smooth shapes. However, one of ordinary skill in the art will recognize that in reality, different components may have non-uniform thicknesses and / or irregular shapes. Descriptions and details of well-known features (e.g., delivery mechanisms, cables, capsules, catheters, etc.) and techniques may be omitted to avoid obscuring other features. Elements in the figures are not necessarily drawn to scale. To enhance understanding of the exemplary embodiments, dimensions of some features may be exaggerated relative to other features. One of ordinary skill in the art will appreciate that cross-sectional views are not drawn to scale and should not be considered to represent proportional relationships between different regions / layers. Additionally, while certain features are shown with straight 90 degree edges or regular planes, in reality, such features may be more "rounded" and gradually sloped.

[0014] Moreover, those skilled in the art will understand that aspects described with reference to one embodiment are applicable to and may be used with other embodiments, even if not explicitly stated. There are many embodiments described and illustrated herein, and the disclosure is not limited to any single aspect or embodiment thereof, nor to any combination and / or permutation of such aspects and / or embodiments. Each aspect and / or embodiment thereof of the disclosure may be employed alone or in combination with one or more of the other aspects and / or embodiments of the disclosure. For the sake of brevity, certain permutations and combinations are not otherwise described and / or illustrated herein. [Brief description of the drawings]

[0015] [Figure 1] FIG. 1 illustrates an exemplary marker according to an embodiment of the present disclosure. [Figure 2A] 1 is a cross-sectional view of an exemplary marker according to an embodiment of the present disclosure. [Figure 2B] 1 is a cross-sectional view of an exemplary marker according to an embodiment of the present disclosure. [Diagram 3] FIG. 1 illustrates an exemplary marker disposed on an exemplary brachytherapy needle or catheter according to the present disclosure. [Figure 4] 1 illustrates an example induction signal report generated by an electromagnetic (EM) sensor device for detecting an example marker according to an embodiment of the present disclosure. [Figure 5A] FIG. 1 illustrates an exemplary 3D image from a CT / Cone Beam Computed Tomography (CBCT) scan of a brachytherapy device catheter including a marker according to an embodiment of the present disclosure. [Figure 5B] FIG. 1 illustrates an exemplary 3D image from a CT / Cone Beam Computed Tomography (CBCT) scan of a brachytherapy device catheter including a marker according to an embodiment of the present disclosure. [Figure 5C]FIG. 1 illustrates an exemplary 3D image from a CT / Cone Beam Computed Tomography (CBCT) scan of a brachytherapy device catheter including a marker according to an embodiment of the present disclosure. [Figure 5D] FIG. 1 illustrates an exemplary 3D image from a CT / Cone Beam Computed Tomography (CBCT) scan of a brachytherapy device catheter including a marker according to an embodiment of the present disclosure. [Figure 6A] 1A-1C illustrate exemplary magnetic resonance images of a Nitinol marker compared to a Nitinol marker with a coating, according to embodiments of the present disclosure. [Figure 6B] 1A-1C illustrate exemplary magnetic resonance images of a Nitinol marker compared to a Nitinol marker with a coating, according to embodiments of the present disclosure. [Figure 7] 1 is a flowchart of an exemplary method for determining an afterloader treatment plan using markers according to the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] It should be noted that the descriptions set forth herein are merely exemplary in nature and are not intended to limit the subject embodiments or the application and use of such embodiments. Any implementation described herein as exemplary should not be construed as preferred or advantageous over other implementations. Rather, the term "exemplary" is used in the sense of example or "illustration" rather than "ideal." The terms "comprising," "including," "having," "having," and variations thereof are used synonymously to indicate or describe non-exclusive inclusion. Thus, devices or methods using such terms do not include only those elements or steps, but may include other elements and steps inherent to such devices and methods not expressly recited. Furthermore, terms such as "first," "second," and the like are used herein not to indicate any order, quantity, or importance, but rather to distinguish one element from another. The term "distal" refers to a direction away from the user or operator and toward the subject. On the other hand, the term "proximal" refers to a direction closer to the user or operator and away from the subject.

[0017] The singular forms "a," "an," and "the" include the plural unless the context dictates otherwise. The terms "approximately" and "about" indicate approximately the same as a referenced numerical value or value. As used herein, the terms "approximately" and "about" should generally be understood to encompass ±5% of the specified amount or value. All ranges are understood to include endpoints, for example, a distance of 1.0 cm to 5.0 cm includes distances of 1.0 cm, 5.0 cm, and all values ​​therebetween.

[0018] The term "brachytherapy instrument" may be used to refer to one or more of a radioactive or dummy source, a brachytherapy applicator, a cable and / or capsule for moving a radioactive or dummy source, or a rod, transfer tube, needle, catheter, obturator, or guidewire used during insertion or use of a radioactive or dummy source.

[0019] Brachytherapy typically includes both a treatment planning phase and a treatment delivery phase. Medical three-dimensional (3D) imaging, such as CT, CBCT, and / or MRI, can be used to generate a conformal radiation dose plan for HDR brachytherapy during treatment planning. Conformal radiation dose planning can be performed during the treatment delivery phase, during which the radioactive brachytherapy source can be guided to one or more parking locations within the body. To do this, an afterloader, for example, a Flexitron afterloader by Elekta, can be calibrated with a dose plan based on one or more 3D patient images. Calibration of the afterloader can generally be performed by identifying landmarks in the medical image, such as recognizing the tip of a needle or the luminal tip of an applicator, although such landmarks may not be obvious or may be difficult to reconstruct in a 3D medical image.

[0020] On the other hand, exemplary embodiments of the present disclosure are directed to specially designed markers that can be associated with brachytherapy applicators, needles, or other brachytherapy instruments. These markers can improve the measurement of the marker's location in CBCT, CT, and MR images, and can improve the measurement by the afterloader, for example, by the indexer length. Fixed marker positions can be defined for each applicator or catheter, so that the distance from the applicator or catheter's beginning (original zero point in the case of afterloaders such as Elekta's Flexitron afterloader) to the marker is a fixed distance depending on the type of applicator or catheter used. For example, the afterloader's indexer length can be zeroed at the marker point in the 3D medical image, thereby allowing the 3D dwell position to be scaled to the indexer length in the afterloader treatment plan. Exemplary markers incorporated into the brachytherapy instrument (e.g., applicator, needle, and / or catheter) allow the afterloader source steering to be calibrated to a dose planning system, e.g., an Elekta Oncentra Brachy dose planning system, and calibrated to the afterloader treatment plan provided. As a result, embodiments of the present disclosure can provide more direct and more precise afterloader calibration.

[0021] FIG. 1 illustrates a marker 10 configured for use with one or more brachytherapy devices. The marker 10 may be annular and may include a central opening 12. One skilled in the art will recognize that the marker 10 may have a variety of shapes (such as those shown in FIG. 2B). For example, the marker 10 may be sized to be attached to or incorporated as part of a brachytherapy catheter or needle, transfer tube, catheter connector, and / or brachytherapy applicator (e.g., along a channel or catheter in the applicator). Thus, the marker 10 may have an inner diameter (i.e., the diameter of the central opening 12) configured to fit around a conventional 2 mm needle or 3 / 4 mm catheter of the applicator.

[0022] As mentioned above, it is desirable to achieve accurate placement of the radiation source when performing brachytherapy. To determine whether an applicator, cable, wire, catheter, needle, or other brachytherapy device is correctly placed within a patient, the device may include one or more markers 10 at known locations of the brachytherapy device. For example, if the marker 10 is included in a distal region of the wire, catheter, cable, or needle, this may be known by tracking the distance the wire, catheter, cable, or needle has been inserted into the patient. In some instances, the location of the marker 10 may be imaged (e.g., using CT imaging) to determine the correct placement of the brachytherapy device within the subject. An afterloader may then be used to position the radiation source within the subject so that it is aligned with the marker 10. Traditionally, bulky spherical markers are used to allow medical personnel to guide the source to the central region of the marker, and software may be used to locate the center of the marker for positioning. The use of bulky spherical markers may not be useful for delivering radiation treatment to smaller areas and / or for use with smaller brachytherapy instruments.

[0023] Furthermore, conventional markers may only be compatible with CT images taken during treatment planning and patient pre-treatment, and may not be compatible with MR imaging that may be used during treatment administration. As a result, current brachytherapy workflows may involve CT scans after placement of the brachytherapy applicator and before delivery of the radiation source to attempt to determine correct placement of the applicator and thereby ensure correct placement of the radiation source during treatment. Positioning of the radiation source relative to the target region selected for treatment may be improved if the actual location of the source is directly monitored. This direct monitoring may be made possible by markers designed for use with both CT imaging during treatment planning and MRI, e.g., real-time MR imaging, taken during placement of the brachytherapy device and / or delivery of the radiation source. Markers according to the present disclosure may address one or more of the above problems.

[0024] 1 and 2A, the inner diameter of the marker designated B may be about 0.50 mm to about 3.00 mm, about 1.00 mm to about 2.50 mm, or about 1.50 mm to about 2.00 mm. In some embodiments, the inner diameter B may be about 0.75 mm to about 2.25 mm. Depending on what the brachytherapy device marker 10 is being used in conjunction with (e.g., what it is positioned on, in, or otherwise), the inner diameter B may be, for example, about 0.50 mm, about 0.75 mm, about 1.00 mm, about 1.25 mm, about 1.50 mm, about 1.75 mm, about 2.00 mm, about 2.25 mm, about 2.50 mm, about 2.75 mm, or about 3.00 mm.

[0025] The thickness of the marker 10, designated C, may be from about 0.25 mm to about 1.25 mm. Thickness C may be, for example, about 0.25 mm, about 0.30 mm, about 0.35 mm, about 0.40 mm, about 0.45 mm, about 0.50 mm, about 0.55 mm, about 0.60 mm, about 0.65 mm, about 0.70 mm, about 0.75 mm, about 0.80 mm, about 0.85 mm, about 0.90 mm, about 0.95 mm, about 1.00 mm, about 1.05 mm, about 1.10 mm, about 1.15 mm, about 1.20 mm, or about 1.25 mm. The outer diameter of the marker 10, designated A, may be about 1.00 mm to about 5.50 mm, for example, about 1.25 mm to about 5.25 mm, about 1.50 mm to about 5.00 mm, or about 1.75 mm to about 4.75 mm. In other examples, the outer diameter A may be about 2.00 mm to about 4.00 mm. The outer diameter may be, for example, about 1.00 mm, about 1.25 mm, about 1.50 mm, about 1.75 mm, about 2.00 mm, about 2.50 mm, about 3.00 mm, about 3.50 mm, about 4.00 mm, about 4.50 mm, about 5.00 mm, about 5.25 mm, or about 5.50 mm.

[0026] As previously discussed, the marker 10 need not be annular. For example, one or more surfaces of the marker 10 may be flat and / or may have varying curvature. In the embodiment of FIG. 2B, a disc-shaped marker 20 has a planar distal surface 13, a planar proximal surface 15, an outer wall 17 extending between the distal surface 13 and the proximal surface 15, and an inner wall 19 extending between the distal surface and the proximal surface. The inner wall 19 may define a central opening of the marker 12. The marker 20 may have dimensions similar to those previously described with respect to the marker 10, but the marker 20 may have, for example, a rectangular cross-sectional shape and thus may not have the same length and thickness (i.e., width). The length of the marker 10, designated D, may be about 0.25 mm to about 0.75 mm. The length of the marker may be, for example, about 0.30 mm, about 0.40 mm, about 0.50 mm, about 0.60 mm, or about 0.70 mm. In some embodiments, length D may be different than thickness C (above), or in some embodiments, length D and thickness C may be equal dimensions.

[0027] 2A and 2B, a marker according to the present disclosure can include an inner ring 14 and an outer coating 16. The inner ring 14 can be copper, brass, gold, silver, titanium, or a combination or alloy thereof. In other examples, the inner ring 14 can be copper, brass, or a combination thereof. The outer coating 16 can be nickel, iron, or another ferromagnetic material, or a combination of ferromagnetic materials, such that the outer coating does not cause significant artifacts in MRI imaging. In some examples, the outer coating 16 can be, for example, nickel, iron, cobalt, NiCo, magnetite, or iron oxide. In some embodiments, the outer coating 16 does not include magnetic steel. In some examples, the outer coating 16 can be composed only of nickel.

[0028] The thickness of the outer coating 16, designated E, may be about 1 μm to about 30 μm, e.g., about 2 μm to about 27 μm, about 3 μm to about 24 μm, or about 4 μm to about 20 μm. In some examples, the thickness of the outer coating 16 may be about 2 μm to about 12 μm. The thickness of the outer coating 16 may be, for example, about 4 μm, about 6 μm, about 8 μm, about 10 μm, about 12 μm, about 14 μm, about 16 μm, about 18 μm, about 20 μm, about 22 μm, about 24 μm, about 26 μm, about 28 μm, or about 30 μm. The thickness of the outer coating 16 may be uniform around the inner ring 14.

[0029] In some exemplary embodiments, the exemplary marker 10 can have an inner ring formed from copper or brass in a ring shape having a diameter of 0.25 mm to 0.5 mm and can have a nickel or iron oxide coating of about 1 μm to about 14 μm, e.g., about 2 μm to about 12 μm, about 5 μm to about 10 μm, or about 6 μm to about 8 μm.

[0030] Artifacts, when referring to CT and MRI scans, are abnormalities seen during visual display that are not present in the original object. Large artifacts may obscure and / or interfere with MRI scans, making it impossible to visually assess the target area. However, small artifacts may be beneficial. For example, small artifacts may be landmarks relative to the surrounding anatomical structures, allowing a radioactive or dummy source to be accurately aimed at the target area. The material and / or size of the marker 10 may be designed to produce small artifacts in MRI and CT scans and may be compatible with both imaging modalities. For example, copper and brass are useful for CT scans because they are good conductors, while nickel may produce small but visible artifacts when used in MRI scans, compared to other materials such as magnetic steel, which may produce large artifacts. Thus, the inner ring 14 may be visible in CT / CBCT scans, and the outer coating 16 may be visible in MRI scans. Thus, the marker 10 according to the present disclosure may be used in both CT / CBCT and MRI scans.

[0031] With reference to FIG. 3, one or more markers 10 according to one or more embodiments of the present disclosure can be used with a brachytherapy device 30. For example, the central opening of the marker 10 of FIG. 3 can be configured to fit around at least a portion of the brachytherapy device 30. The brachytherapy device 30 can be, for example, a needle, a catheter, a transfer tube, an applicator, a cable, or a guidewire. For example, one or more markers 10 can be associated with a predetermined location on the applicator, which can be a known distance from a suitable reference point. For example, the marker 10 can be used to indicate a distal end of a relevant structure, such as a cavity in the applicator, or the marker 10 can be used to indicate a relevant location, such as a source parking location, in the brachytherapy device. One or more markers 10 can be placed on the applicator to define a location, and the distance from the start of the applicator to the marker 10 can be a fixed distance.

[0032] In some embodiments, one or more markers 10 can be incorporated as part of a breast catheter button for end-point detection of the brachytherapy source. In some aspects, one or more markers 10 can be incorporated into the transfer tube / catheter connector to help determine when the catheter and / or applicator is properly connected to the transfer tube. In yet other aspects, one or more markers 10 can be incorporated into the end of the applicator or catheter for end-point detection of the brachytherapy source.

[0033] The marker 10 may be included as part of the brachytherapy instrument to allow the afterloader to measure the indexer length that belongs to the position of the marker 10. This measurement can be done using electromagnetic induction caused by a conductive ring (e.g., the marker 10) and a coil included (e.g., built in or added to) one or more of the source cable, the check cable, and / or the dummy cable. The marker 10 is also clearly visible in the 3D patient image, so that the 3D position of the center of the ring can be measured in the CT, CBCT, and / or MR images by the dose planning system, e.g., the marker point of the Oncecentra Brachy. This method of measuring the marker in the patient coordinate system of the 3D image using the indexer length of the afterloader source allows the afterloader to be calibrated to or by the 3D image of the dose plan. It may therefore be possible to more precisely position the brachytherapy source with respect to the predetermined dwell position generated by the dose plan.

[0034] As previously mentioned, one or more markers 10 according to the present disclosure can be used as part of or in combination with a high dose rate (HDR), low dose rate (LDR), or pulsed dose rate (PDR) integrated brachytherapy treatment system. The integrated brachytherapy treatment system can include an afterloader and a radiation source associated with an electromagnetic coil. Alternatively, instead of an electromagnetic coil, the integrated brachytherapy treatment system can include a Hall sensor associated with a cable and a permanent magnet associated with one or more of the markers 10. In other embodiments, a capacitance sensor can be used in the integrated brachytherapy treatment system to measure changes in capacitance.

[0035] In the exemplary embodiment described herein, the afterloader may be configured to measure the induction of the magnetic source caused by the coil. The marker 10 may be incorporated as part of one or more brachytherapy instruments, such as an applicator, a catheter, or a needle. The marker 10 may be clearly recognizable in both MRI, CT, and CBCT images. The integrated system may include a planning system, such as an HDR planning system, configured to reconstruct the applicator and markers in a 3D image and to reconstruct the 3D position of the marker 10. The HDR planning system may be configured to generate dose dwell positions for irradiation. Software associated with the afterloader may be configured to calculate the indexer length of the dose plan dwell position. A calibration software module may be further designed to calibrate the treatment plan of the indexer length to the dose plan using the calibration of the marker 10 of the afterloader by the planning system.

[0036] Markers according to the present disclosure may be coupled to the applicator of a brachytherapy device, as shown in FIG. 3 and described above. Once the applicator with associated markers is inserted into the patient, CT and MRI scans can be performed in real time, as the marker components, e.g., inner ring and outer coating, may be adapted for use across both imaging modalities, as described in detail above. High quality 3D imaging of the patient, including CT, CBCT, and / or MRI, can allow for more accurate conformal radiation dose planning for HDR brachytherapy.

[0037] After creating a conformal radiation dose plan, HDR brachytherapy sources or dummy sources can be directed to the predetermined dwell positions of the treatment plan. To direct the radiation source, the afterloader can be calibrated with a dose plan based on the patient image. Currently, there is no direct way to calibrate the dose plan to the afterloader treatment plan. In current treatments, this can be done by recognizing the tip of the needle or the luminal tip of the applicator, but the tip may not be obvious or may be difficult to reconstruct in the 3D image. In general, the accuracy of positioning the brachytherapy source can be about ±1.5mm, or about ±0.8mm using the Flexitron afterloader by Elekta. For MRI, this type of treatment plan may not be available because the markers are not compatible with MR imaging.

[0038] Since the markers according to the present disclosure may be more clear and visible in the 3D image, the position of the marker can be more accurately measured in the image or by the afterloader to generate the indexer length. This measuring step can be done by measuring the electromagnetic induction caused by the marker and the coil on the afterloader source cable. Since the exemplary markers of the present disclosure are visible in the CT and MRI images, the position of the center of the marker can be measured in the image by the marker point of the Oncecentra® Brachy dose plan. The afterloader indexer length can be zeroed at the marker point in the 3D image, thereby allowing the 3D dwell position to be scaled to the indexer length of the afterloader treatment plan. Thus, the markers built into the applicator can calibrate the afterloader source to the dose planning system, thereby allowing a more direct and / or more precise calibration between the dose planning system, such as the Oncecentra® Brachy dose planning system, and the afterloader treatment plan. The ability to generate CT and MRI images while positioning the applicator may allow the radiation source to be more accurately aimed at the determined dwell position required by the dose plan. In some embodiments, this direct calibration of the afterloader index length to the 3D patient image may be used to increase the accuracy of brachytherapy source positioning to approximately ±0.5 mm, and MRI calibration may also be available.

[0039] Referring to FIG. 4, the brachytherapy instrument 40 can include an afterloader 42. The afterloader 42 can include a selector 44 and a safety device 46. The safety device 46 can be located within the selector 44. One or more transfer tubes 48 can be used to connect the afterloader 42 to an applicator 50, which can be positioned within the subject. An electromagnetic sensor (e.g., a coil) can be located at an end region of the cable. For example, the source cable, the check cable, and / or the dummy cable can include an electromagnetic sensor located at a distal region. In an exemplary embodiment in which the source cable includes an electromagnetic sensor, the sensor can be located, for example, proximal or distal to the radiation source. In either case, the distance between the source and the sensor can be known. The source cable, the check cable, and / or the dummy cable including the electromagnetic sensor at the distal region can be moved from the afterloader 42 through the transfer tube 48 into the applicator 50. The sensor (e.g., a coil) can be used to measure electromagnetic induction changes as the sensor moves past a marker of the present disclosure. For example, a copper or brass ring marker can produce a strong change in the electromagnetic induction signal when the cable and associated electromagnetic sensor pass through or are guided by the marker due to the good conductance properties of copper and / or brass. When an electromagnetic source is placed in the applicator, the sensor can detect the change in magnetic induction when it is guided through or by the marker associated with the brachytherapy device. The markers can each be located at a park position so that the electromagnetic signal can indicate the respective park position.

[0040] For example, the three markers in Figure 4 can cause corresponding signal changes in the region designated by AA. Marker 52a can cause a change in electromagnetic induction measured at point 53a, marker 52b can cause a change in electromagnetic induction measured at point 53b, and marker 52c can cause a change in electromagnetic induction measured at point 53c. Additionally, marker 52d can be located at the distal end of transfer tube 48 to cause a change in electromagnetic induction measured at point 53d to indicate that the cable has been threaded from transfer tube 48 into applicator 50. As previously mentioned, markers 52a, 52b, 52c can be separate from applicator 50 and attached to applicator 50 prior to insertion into the patient, or markers 52a, 52b, 52c can be incorporated as part of applicator 50 or any other suitable brachytherapy device. Markers 52a, 52b, 52c may be oriented adjacent to or at least partially surround a path traveled by the afterloader cable and / or associated radiation source. Additionally, while three markers are shown in Figure 4, one skilled in the art will recognize that fewer (e.g., one or two) or more markers may be associated with applicator 50.

[0041] In embodiments where the electromagnetic sensor is incorporated as part of the dummy cable and / or check cable, after the location of the marker is detected by the sensor, the cable and electromagnetic sensor device can be withdrawn from the applicator 50 and the transport tube 48 and back into the afterloader 42. The brachytherapy source cable can then be inserted into the transport tube 48 and the applicator 50. In some embodiments, the source cable may include an electromagnetic sensor (e.g., a coil) proximal or distal to the radiation source. In some aspects, after the HDR source is inserted and the target location of the HDR source is confirmed, the dummy cable and / or check cable including the electromagnetic sensor can be threaded through the transport tube 48 and the applicator 50.

[0042] 5A-5D show exemplary 3D images from a CT / CBCT scan of a catheter and exemplary markers of a brachytherapy device according to one or more embodiments of the present disclosure. 5A-5D show views of oblique cross-sectional 3D CT / CBCT images taken with a suitable treatment planning system, such as the Oncentra® Brachy by Elekta. Treatment planning systems, such as the Oncentra® Brachy, can create a 3D representation of one or more brachytherapy devices, including associated markers, by combining multiple two-dimensional (2D) images. For example, a 2D sagittal view (FIG. 5A), a 2D transverse view (FIG. 5B), and a 2D coronal view (FIG. 5C) can be combined to form a 3D image (FIG. 5D). FIG. 5D is a 3D visualization of such a catheter. The catheter, e.g., a plastic catheter, and one or more marker rings according to the present disclosure are clearly visible and can be reconstructed as marker points in a dose plan. In the CT / CBCT images, the marker (in this example, the copper marker ring) may appear as a white dot (shown as a black dot for contrast in Figures 5A-D) at 2800-3000 Hounsfield Units (HU). The plastic catheter may be visible at 750 HU because the plastic may have improved CT visibility with BaSO4, which may give better CT / CBCT contrast when measured on the HU scale. In other CT / CBCT images, the contrast of the marker may be even clearer because standard applicator tubes are often made from regular unreinforced plastics, so the plastic may appear closer to 100 HU, the air in the catheter may be -1000 HU, and the contrast may be 1100 HU.

[0043] In actual CT images, the markers are displayed as two white dots and the catheter may appear as a softer white line. In Figures 5A-5C, for clarity, the two markers are shown as two black dots and the catheter is displayed as an outline. In treatment planning software such as Oncentra® Brachy, the optimized dwell positions for the markers and dose planning are stored in 3D coordinates and these can be used to define the reconstructed catheter. The markers can be used to indicate the official marker points used in Oncentra® Brachy planning or other suitable treatment planning software.

[0044] 6A and 6B compare a standard nitinol marker (FIG. 6A) with an exemplary marker according to the present disclosure (FIG. 6B). FIG. 6A represents an MR image of a nitinol marker positioned on a 6F catheter. The nitinol marker may be located toward the distal end of the catheter at a predetermined location, e.g., 15 mm, 20 mm, and / or 24 mm from the distal end. These nitinol markers are generally used only for CT scans. The catheter and nitinol marker may be inserted into the patient until the marker reaches a specified distance within the patient. An afterloader may then be used to position the radiation source within the catheter such that the source is lined up with the center of the marker. As can be seen in the MR image of FIG. 6A, the nitinol marker is barely visible within the dark line representing the catheter, making it a poor marker.

[0045] FIG. 6B represents an MR image taken at the oblique plane where a 6 French (F) catheter is located. The catheter includes a ring-shaped marker made of copper with a nickel coating, in this case 10 μm of nickel coating. The marker is clearly visible in the MRI scan of FIG. 6B. The nickel artifact is a visible bipolar artifact, and the center of the artifact may coincide with the center position of the copper ring. Using the MR image with the marker of FIG. 6B, the clinician may be able to more accurately guide the brachytherapy source to the target area and accurately align the source to the central area of ​​the marker. The marker of the present disclosure may increase the accuracy of brachytherapy placement, since the marker can be aligned to a predetermined dwelling position. The accuracy of marker positioning of the Oncecentra® Brachy using the marker of FIG. 6B may be ±0.5 mm or better.

[0046] As mentioned above, conventional markers can only be used for CT scans. The markers according to the present disclosure may allow for CT scans or MRI scans or both to be performed while simultaneously treating the patient or while checking the position of the applicator or other brachytherapy instrument inside the body, for example, using a dummy or check cable. Such an advantage may allow the medical personnel performing the brachytherapy to determine in real time, for example, whether the radiation source is aimed at the correct location and / or whether the location of the marker, and therefore the location of the radiation source or dummy source, can be measured more directly. In radiation therapy, precise location is necessary to ensure that normal healthy tissue is not damaged and that the targeted cancerous tissue is treated.

[0047] The afterloader software can be integrated into dose planning software, such as Oncecentra Brachy, to generate an afterloader treatment plan. In such an embodiment, the marker positions measured in 3D images by the Oncecentra Brachy and the results of measurements of the afterloader's electromagnetic induction sensors (e.g., coils) can be taken into account for the calibrated indexer length of the dwell position, as described below.

[0048] As mentioned above, the markers according to the present disclosure may allow a more direct and / or real-time calibration of the indexer length of the afterloader with the 3D position of the marker in the patient imaging system. The brachytherapy workflow may be modified to accommodate this new calibration. An extra software module in the afterloader may be configured to handle the calibration, allowing the new software module to read out the 3D dwell positions from the dose planning system. The 3D positions of the markers may be displayed or highlighted, for example, by being shown in a contrasting color, for example, red, yellow, orange, green, or blue. The indexer length of the marker position may be available by calibration. The indexer length of the dose planning dwell position may be calculated from the distance between the marker point and consecutive dwell positions starting from the position closest to the marker or starting from the dwell position furthest from the marker. The calculated indexer length may then be stored in the afterloader treatment plan.

[0049] FIG. 7 is a flow chart illustrating a method for determining an afterloader treatment plan according to the present disclosure using markers according to one or more embodiments of the present disclosure. The method can be performed by an individual processor or multiple processors in communication with each other. A brachytherapy applicator can be placed in the patient to directly calibrate the position of the source. A three-dimensional CT image, CBCT image, and / or MR image of the patient can then be taken, and a dose plan including the park position can be created in the 3D image. The position of the markers can be displayed in the 3D image. The patient can be removed from the MRI or CT device, and then the afterloader can be connected to the brachytherapy applicator. To calibrate the brachytherapy system, a dummy source can be moved to the most distal park position (or in some embodiments, the most proximal park position). An electromagnetic sensor (e.g., a coil), as part of the source, can generate a signal through the marker, which allows the indexer length to be measured by the afterloader.

[0050] To perform the steps of FIG. 7, the indexer length of the marker position can be received from the afterloader. Step 70 can include determining the most proximal dwell position relative to the 3D marker position. Step 72 can include calculating the distance difference between the closest dwell position and the marker position. The distance delta (ΔD) can be equal to ΔD=d(dwell(proximal position)-marker(position)). Step 74 can include calculating the indexer length from the distance from the dwell to the marker and the measured calibrated indexer length. In this situation, the indexer length dwell of the closest dwell position=the indexer length of the marker+ΔD. Step 76 can include repeating steps 70, 72, and 74 until the indexer lengths of all dwell positions in the positive direction have been calculated. For example, indexer length dwell(n+1)=indexer length(n)+delta(dwell(n+1)-dwell(n)). Step 78 includes repeating steps 70, 72, and 74 to calculate the indexer lengths for all dwell positions in the negative direction. The same loop can be done in the reverse direction until all dwell positions in the negative direction have also been determined. Those skilled in the art should recognize that the dwell positions can be determined in the negative direction and then in the positive direction, as opposed to first in the positive direction and then in the negative direction, and the equations would simply be changed accordingly. The dwell positions may be saved as indexer lengths in the afterloader treatment plan.

[0051] In some embodiments, instead of obtaining the reference indexer length from the after loader, the indexer length to the marker can be used as the reference indexer length. In this regard, in the planning system, the distance from the marker to the dwell position (i) can be measured, which can be delta(i). Then, the indexer length of the dwell position (i) can be determined. In this situation, the indexer length (i) can be equal to the reference indexer length, which can be equal to delta(i).

[0052] Alternatively, the source can be indirectly calibrated, for example, when a marker is incorporated into the brachytherapy applicator or needle at a predetermined distance from the entrance of the brachytherapy instrument (e.g., needle or catheter). For example, the marker can be located 20 cm from the entrance of the catheter. The source can be guided to 20 cm (e.g., with an accuracy of 0.25 mm) using a calibration ruler associated with the afterloader, and the indexer length can be saved. This value can be used as the reference indexer length, and the indexer length (i) can be calculated from the 3D CT and / or MR images that include delta(i) per dwell position (i). In this way, the indexer length can be calculated using the reference indexer length and the ΔD per dwell position determined from the 3D images.

[0053] In some embodiments, at least two markers can be used per catheter or needle, with at least one marker positioned at the distal end of the catheter or needle and at least one marker positioned at the proximal end of the catheter or needle. The path and step size of the afterloader can be controlled and measured. If the marker position is also visible in the 3D planning image, a double direct calibration can be performed. Or, if both markers are placed at predetermined positions on the catheter or needle and the markers are visible in the 3D image, an indirect calibration can be performed.

[0054] As with any programmable logic, such logic may be executed on a commercially available processing platform or a dedicated device. Those skilled in the art will appreciate that embodiments of the disclosed subject matter may be practiced with a variety of computer system configurations, including multi-core multiprocessor systems, minicomputers, mainframe computers, computers linked or clustered with distributed functionality, as well as pervasive and small computers that may be embedded in virtually any device.

[0055] For example, the above embodiments can be implemented using at least one processor device and memory. The processor device may be a single processor (e.g., associated with an afterloader), multiple processors (e.g., associated with an afterloader and / or a separate processor used for treatment planning, etc.), or a combination thereof. The processor device may have one or more processor "cores."

[0056] Various embodiments of the present disclosure, such as those described above in the example of FIG. 7, can be implemented using a processor device. After reading this specification, it will become apparent to one of ordinary skill in the art how to implement embodiments of the present disclosure using other computer systems and / or computer architectures. Although operations may be described as sequential processes, some of the operations may in fact be performed in parallel, simultaneously, and / or in a distributed environment, and may be performed by program code stored locally or remotely for access by a single or multi-processor machine. Additionally, in some embodiments, the order of operations may be rearranged without departing from the spirit of the disclosed subject matter.

[0057] It should be understood that a device used to access the afterloader treatment platform 80, such as a user device or a source device, may include a central processing unit (CPU). Such a CPU may be any type of processor device, including, for example, any type of dedicated or general-purpose microprocessor device. As will be appreciated by those skilled in the art, the CPU may be a single processor in a multi-core / multi-processor system, such systems operating alone or in a cluster of computing devices operating in a cluster or server farm. The CPU may be connected to a data communications infrastructure, such as a bus, message queue, network, or multi-core message passing scheme.

[0058] It should further be appreciated that a device used to access the afterloader treatment platform 80, such as a user device or a source device, may include a main memory, e.g., random access memory (RAM), and may include a secondary memory. The secondary memory, e.g., read only memory (ROM), may be, for example, a hard disk drive or a removable storage drive. Such removable storage drives may include, for example, floppy disk drives, magnetic tape drives, optical disk drives, flash memory, and the like. The removable storage drive in this example reads and / or writes to a removable storage unit in a well-known manner. Removable storage units include floppy disks, magnetic tapes, optical disks, and the like, which are read and written by the removable storage drive. As one skilled in the art would appreciate, such removable storage units generally include computer usable storage media on which computer software and / or data are stored.

[0059] In alternative implementations, the secondary memory may include other similar means by which computer programs or other instructions may be loaded into the device, such as program cartridges and cartridge interfaces (such as those found in video game devices), removable memory chips (such as EPROMs or PROMs) and associated sockets, and other removable storage units and interfaces by which software and data may be transferred from a removable storage unit to the device.

[0060] It should further be appreciated that a device used to access the afterloader treatment platform 80, such as a user device or a source device, may include a communications interface ("COM"). The communications interface allows software and data to be transmitted between the afterloader device and an external device. Communications interfaces include modems, network interfaces (such as Ethernet cards), communications ports, PCMCIA slots and cards, and the like. The software and data transmitted over the communications interface may be in the form of signals, which may be electronic, electromagnetic, optical, or other signals receivable by the communications interface. These signals may be provided to the communications interface via a communications path of the device, which may be implemented using, for example, wire or cable, optical fiber, telephone line, cellular phone link, RF link, or other communications channel.

[0061] The hardware elements, operating systems, and programming languages ​​of such devices are conventional in nature and are presumed to be sufficiently familiar to those skilled in the art. The device used to access the afterloader treatment platform may also include input and output ports for connecting to input and output devices such as a keyboard, mouse, touch screen, monitor, display, etc. Naturally, the various server functions may be implemented in a distributed manner across several similar platforms to distribute the processing load. Alternatively, the server may be implemented by suitable programming of one computer hardware platform.

[0062] The systems, apparatus, devices, and methods disclosed herein are described in detail by way of example and with reference to the figures. The examples described herein are merely examples and are presented to supplement the description of the apparatus, devices, systems, and methods described herein. Features or components shown in the drawings or described below should not be considered essential for any particular implementation of any of the apparatus, devices, systems, or methods, unless specifically designated as essential. Any identification of specific techniques, arrangements, etc. in this disclosure is either related to the specific examples presented or is merely a general description of such techniques, arrangements, etc. Identification of specific details or examples is not intended to be, and should not be, construed as essential or limiting, unless specifically designated as such. Failure to specifically describe a combination or subcombination of components should not be understood to indicate that any combination or subcombination is not possible. It will be understood that changes can be made to the disclosed and described examples, arrangements, configurations, components, elements, apparatus, devices, systems, methods, etc., and that such changes may be desirable for particular applications. Also, for any described method, whether or not the method is described in conjunction with a flow diagram, unless otherwise specified or required by context, it should be understood that any explicit or implicit ordering of steps performed in performing the method does not imply that those steps must be performed in the order presented, but may instead be performed in a different order or in parallel.

[0063] Throughout this disclosure, references to components or modules generally refer to items that can be logically grouped together to perform a function or group of related functions. The components and modules can be implemented in software, hardware, or a combination of software and hardware. The term "software" is used broadly to include executable code, e.g., machine-executable or machine-interpretable instructions, as well as data structures, data stores, and computational instructions stored in any suitable electronic format, including firmware, and embedded software. The terms "information" and "data" are used broadly to include a wide variety of electronic information, including executable code; content, such as text, video data, and audio data; and various codes or flags. The terms "information," "data," and "content" may be used interchangeably where the context permits.

[0064] The invention further relates to the following examples. First example: 1. A method for positioning a brachytherapy device within a subject, comprising: Inserting a brachytherapy device into the subject, the brachytherapy device including a marker, the marker comprising: an inner ring constructed from one or more of copper, brass, gold, silver, or titanium; an outer coating having a thickness of about 1 μm to about 30 μm, the outer coating being composed of one or more of nickel or iron oxide; a central opening having a diameter of about 0.50 mm to about 3.00 mm; and generating a magnetic resonance image of the brachytherapy device and the marker when inserted into the subject, wherein the inner ring and outer coating of the marker are configured to cause artifacts in the image. The method of the first example, further comprising adjusting a position of the brachytherapy device within the patient based on artifacts occurring in the image. The method of the first example, further comprising generating a computed tomography image of the brachytherapy device. inserting an afterloader cable including an electromagnetic sensor into a brachytherapy device; and detecting the marker using an electromagnetic sensor. The method of the previous example, where the afterloader cable is a dummy cable. The method of any preceding example, further comprising inserting the source cable into the brachytherapy instrument and positioning the radiation source relative to the artifact. The method of any preceding example, wherein the source cable includes a second electromagnetic sensor. The method of any preceding example, wherein the electromagnetic sensor is a coil. Example 2: A brachytherapy device; and a marker, the marker comprising: an inner ring constructed from one or more of copper, brass, gold, silver, or titanium; an outer coating having a thickness of about 1 μm to about 30 μm, the outer coating being composed of one or more of nickel or iron oxide; and a central opening having a diameter of about 0.50 mm to about 3.00 mm. A second example marker where the marker is circular.

[0065] The above disclosed subject matter should be considered as illustrative and not restrictive, and the appended claims are intended to cover all such modifications, enhancements, and other implementations that fall within the true spirit and scope of the present disclosure. Thus, the scope of the present disclosure should be determined by the broadest permissible interpretation of the following claims and their equivalents to the fullest extent permitted by law, and should not be limited or restricted by the foregoing detailed description. Although various implementations of the present disclosure have been described, it will be apparent to one skilled in the art that many more implementations are possible within the scope of the present disclosure. Thus, the present disclosure is not limited except by the appended claims and their equivalents.

Claims

1. A brachytherapy marker, comprising: an inner ring formed into a closed annular shape and made of one or more of copper, brass, gold, silver, or titanium; an outer coating covering the inner ring and composed of one or more of nickel or iron oxide, the outer coating having a thickness of 1 μm to 30 μm; a central opening defined by an inner diameter of the inner ring, the central opening having a diameter between 0.50 mm and 3.00 mm.

2. The brachytherapy marker of claim 1 , wherein the inner ring is copper or brass.

3. 3. The brachytherapy marker of claim 1, wherein the outer diameter of the brachytherapy marker is between 1.00 mm and 5.50 mm.

4. The brachytherapy marker according to any one of claims 1 to 3, wherein the thickness of the outer coating is between 4 μm and 20 μm.

5. The brachytherapy marker according to any one of claims 1 to 4, wherein the diameter of the central opening is between 0.75 mm and 2.25 mm.

6. The brachytherapy marker according to any one of claims 1 to 5, wherein the brachytherapy marker is coupled to a brachytherapy applicator.

7. The brachytherapy marker according to any one of claims 1 to 6, wherein the brachytherapy marker is coupled to a brachytherapy needle.

8. The brachytherapy marker according to any one of claims 1 to 7, wherein the brachytherapy marker is coupled to a brachytherapy catheter.

9. The brachytherapy marker of any one of claims 1 to 8, wherein the brachytherapy marker is coupled to a distal region of a brachytherapy transport tube.

10. 10. The brachytherapy marker of claim 1, wherein when a magnetic resonance image of a brachytherapy device including the brachytherapy marker is generated, the inner ring and the outer coating of the brachytherapy marker are configured to cause artifacts in the image.

11. The brachytherapy marker of claim 10 further comprising means for adjusting a position of the brachytherapy instrument within the patient based on the artifact occurring in the image.

12. means for inserting an afterloader cable including an electromagnetic sensor into said brachytherapy instrument; 12. The brachytherapy marker of claim 10 or 11, further comprising: means for detecting said brachytherapy marker using said electromagnetic sensor.

13. 13. The brachytherapy marker of claim 12, wherein the afterloader cable is a dummy cable.

14. 14. The brachytherapy marker of claim 13, further comprising means for inserting a source cable into the brachytherapy instrument and positioning a radiation source relative to the artifact.

15. The brachytherapy marker of claim 14 , wherein the source cable includes a second electromagnetic sensor.

16. The brachytherapy marker of claim 12 , wherein the electromagnetic sensor is a coil.

Citation Information

Patent Citations

  • Catheter for radiotherapy and catheter assembly for radiotherapy

    JP2000116802A

  • Radioactive medical implant and its manufacturing method

    JP2006326311A

  • Subcutaneous biopsy hole marker device

    JP2006527026A

  • Markers for mri and x-ray visualization

    JP2007528779A

  • Interstitial marker and device for visualizing the marker through imaging modality

    JP2012139509A